Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Zhikun Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Phylogeny, Influenza Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Science and Technology Program of Wuhan, Key Research and Development Program of Hubei Province, 2021 Hubei Provincial Leading Public Health Talents Project.
Abstract (Originalsprache)
The COVID‐19 pandemic had a significant impact on the global influenza vaccination and the epidemics of seasonal influenza. To further explore the molecular epidemiology of influenza viruses and assess vaccine effectiveness, we collected influenza cases in Wuhan during the 2022–2023 influenza season. Among 1312 clinical samples, 312 samples tested positive for influenza viruses using reverse transcription polymerase chain reaction. These positive samples included 146A/H1N1 subtypes (46.8%), 164A/H3N2 subtypes (52.6%) and 2 influenza B virus types (0.6%). Based on the whole genome sequence information of hemagglutinin (HA) and neuraminidase (NA) from 27A/H1N1 influenza virus strains and 26A/H3N2 influenza virus strains obtained in this study, a phylogenetic analysis was conducted. The analysis revealed that all A/H1N1 strains belonged to the evolutionary branch 6B.1A.5a.2a, and they exhibited specific substitutions at positions K71Q, Q206E, E241A, and R276K. Similarly, all A/H3N2 strains were classified into the 3C.2a1b.2a.1a subclade and displayed amino acid substitutions at positions S172H, N175Y, I176T, K187N, and S214P. Notably, the A/H3N2 strains also acquired a new potential glycosylation site at position N174. Using an epitope model, the predicted vaccine effectiveness was assessed for the A/H1N1 and A/H3N2 strains. The predicted vaccine effectiveness against the Wuhan influenza epidemic strain was over 85% for the A/H1N1 vaccine strain. However, the effectiveness against the A/H3N2 vaccine strain was only 48.7%. To further verify the protection of influenza vaccine against circulating influenza viruses in the region, we conducted in vivo and in vitro animal studies. The results of in vitro neutralization experiment showed that rabbit serum antibodies inoculated with quadrivalent isolated influenza vaccine had neutralization ability against all 24 isolated influenza viruses. In vivo experiments showed that vaccinated mice had fewer lung lesions when infected with the influenza strain circulating in Wuhan, suggesting that vaccination can effectively reduce the occurrence of severe lung damage. These findings emphasize the importance of accurately predicting seasonal influenza strains for effective influenza prevention and control, especially during the co‐circulation of SARS‐CoV‐2 and influenza viruses. This study provides valuable information on the seasonal influenza virus in Wuhan during the COVID‐19 pandemic and serves as a basis for vaccine prediction and updates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Wuhan Institute of Biological Products Co. Ltd., Wuhan, China.
- National Engineering Technology Research Center for Combined Vaccines, Wuhan, China.
- National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, Wuhan, China.
- Hubei Provincial Vaccine Technology Innovation Center, Wuhan, China.
ORCID-Profile: Yirong Li
Förderung
- Science and Technology Program of Wuhan
- Key Research and Development Program of Hubei Province
- 2021 Hubei Provincial Leading Public Health Talents Project
Zitieren
APA
Zeng, Z., Jia, L., Zheng, J., Nian, X., Zhang, Z., Chen, L., Chen, X., Li, Y., & Zhang, J. (2024). Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China. Journal of Medical Virology. https://doi.org/10.1002/jmv.29858
Vancouver
Zeng Z, Jia L, Zheng J, Nian X, Zhang Z, Chen L, et al. Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China. Journal of Medical Virology. 2024. doi:10.1002/jmv.29858
BibTeX
@article{Zeng2024,
author = {Zeng, Zhikun and Jia, Lanxin and Zheng, Jiahao and Nian, Xuanxuan and Zhang, Zhegang and Chen, Liangjun and Chen, Xiaoqi and Li, Yirong and Zhang, Jiayou},
title = {Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29858}
}
EUVIMED